221 related articles for article (PubMed ID: 28346091)
1. A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth.
Lal-Nag M; McGee L; Guha R; Lengyel E; Kenny HA; Ferrer M
SLAS Discov; 2017 Jun; 22(5):494-506. PubMed ID: 28346091
[TBL] [Abstract][Full Text] [Related]
2. Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
Kenny HA; Lal-Nag M; White EA; Shen M; Chiang CY; Mitra AK; Zhang Y; Curtis M; Schryver EM; Bettis S; Jadhav A; Boxer MB; Li Z; Ferrer M; Lengyel E
Nat Commun; 2015 Feb; 6():6220. PubMed ID: 25653139
[TBL] [Abstract][Full Text] [Related]
3. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
4. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
Loessner D; Rizzi SC; Stok KS; Fuehrmann T; Hollier B; Magdolen V; Hutmacher DW; Clements JA
Biomaterials; 2013 Oct; 34(30):7389-400. PubMed ID: 23827191
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays.
Tofani LB; Abriata JP; Luiz MT; Marchetti JM; Swiech K
Biotechnol Prog; 2020 Nov; 36(6):e3034. PubMed ID: 32519461
[TBL] [Abstract][Full Text] [Related]
6. Large-scale pharmacological profiling of 3D tumor models of cancer cells.
Mathews Griner LA; Zhang X; Guha R; McKnight C; Goldlust IS; Lal-Nag M; Wilson K; Michael S; Titus S; Shinn P; Thomas CJ; Ferrer M
Cell Death Dis; 2016 Dec; 7(12):e2492. PubMed ID: 27906188
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
8. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.
Lee JM; Mhawech-Fauceglia P; Lee N; Parsanian LC; Lin YG; Gayther SA; Lawrenson K
Lab Invest; 2013 May; 93(5):528-42. PubMed ID: 23459371
[TBL] [Abstract][Full Text] [Related]
9. Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells.
Bregenzer ME; Davis C; Horst EN; Mehta P; Novak CM; Raghavan S; Snyder CS; Mehta G
J Vis Exp; 2019 Jul; (149):. PubMed ID: 31329171
[TBL] [Abstract][Full Text] [Related]
10. Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate.
Lee SY; Teng Y; Son M; Ku B; Hwang HJ; Tergaonkar V; Chow PK; Lee DW; Nam DH
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443536
[TBL] [Abstract][Full Text] [Related]
11. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
12. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
[TBL] [Abstract][Full Text] [Related]
13. Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer.
Xu S; Yang Y; Dong L; Qiu W; Yang L; Wang X; Liu L
Sci Rep; 2014 Jul; 4():5646. PubMed ID: 25008268
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
15. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
[TBL] [Abstract][Full Text] [Related]
16. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
17. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
18. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
19. Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.
Singh M; Close DA; Mukundan S; Johnston PA; Sant S
Assay Drug Dev Technol; 2015 Nov; 13(9):570-83. PubMed ID: 26274587
[TBL] [Abstract][Full Text] [Related]
20. A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells.
Weydert Z; Lal-Nag M; Mathews-Greiner L; Thiel C; Cordes H; Küpfer L; Guye P; Kelm JM; Ferrer M
SLAS Discov; 2020 Mar; 25(3):265-276. PubMed ID: 31658853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]